- Home
- CTOS vs MNKD Comparison
CTOS vs MNKD Comparison
Compare CTOS & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOS
- MNKD
- Stock Information
- Founded
- CTOS 1988
- MNKD 1991
- Country
- CTOS United States
- MNKD United States
- Employees
- CTOS N/A
- MNKD N/A
- Industry
- CTOS Diversified Commercial Services
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- CTOS Consumer Discretionary
- MNKD Health Care
- Exchange
- CTOS Nasdaq
- MNKD Nasdaq
- Market Cap
- CTOS 1.4B
- MNKD 1.2B
- IPO Year
- CTOS N/A
- MNKD 2004
- Fundamental
- Price
- CTOS $5.80
- MNKD $5.44
- Analyst Decision
- CTOS Buy
- MNKD Strong Buy
- Analyst Count
- CTOS 3
- MNKD 5
- Target Price
- CTOS $6.83
- MNKD $10.80
- AVG Volume (30 Days)
- CTOS 688.6K
- MNKD 5.8M
- Earning Date
- CTOS 10-29-2025
- MNKD 11-06-2025
- Dividend Yield
- CTOS N/A
- MNKD N/A
- EPS Growth
- CTOS N/A
- MNKD 149.32
- EPS
- CTOS N/A
- MNKD 0.11
- Revenue
- CTOS $1,901,675,000.00
- MNKD $301,736,000.00
- Revenue This Year
- CTOS $13.58
- MNKD $14.52
- Revenue Next Year
- CTOS $5.18
- MNKD $12.81
- P/E Ratio
- CTOS N/A
- MNKD $49.68
- Revenue Growth
- CTOS 6.21
- MNKD 21.48
- 52 Week Low
- CTOS $3.03
- MNKD $3.38
- 52 Week High
- CTOS $6.64
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- CTOS 48.16
- MNKD 64.50
- Support Level
- CTOS $5.63
- MNKD $5.25
- Resistance Level
- CTOS $5.92
- MNKD $5.77
- Average True Range (ATR)
- CTOS 0.20
- MNKD 0.29
- MACD
- CTOS -0.04
- MNKD -0.00
- Stochastic Oscillator
- CTOS 32.69
- MNKD 57.54
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.